Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 577 results for "biocon"

A Shot In The Arm

Ajay Bharadwaj, MD of Anthem Biosciences, hates people comparing his company with Biocon. While I understand why it crops up, it is unfair to us to be compared all the time, he says. Bharadwaj's peeve stems from the fact that while Biocon is India's ... Businessworld India, 23 hours ago

233 images for biocon

MSN India, 1 week ago
Business Today India, 1 week ago
Money Today, 1 week ago
Pharmafocus, 1 week ago
Livemint.com, 1 week ago
Livemint.com, 1 week ago
Pharma Letter, 4 days ago
1440 WNFL, 1 week ago
Sky News Australia, 1 week ago
Money Control, 1 week ago

PTI - STOCK MUM CLOSE 2 - BHEL

STOCK MUM CLOSE 2 - BHEL Contributed by NAMPA / PTI. 181.35 BHUSH STEEL 446.20 BIOCON LTD. 451.55 BNK OF BAROD 752.60 BNK OF INDIA 221.25 BOSCH LTD 10268.15 BRITANIA IND 880.60 CADILA HEALT 976.85 CAIRN IND* 358.45 CANARA BANK 268.95 ...
 Namibia Press Agency23 hours ago Biocon stock down 4%  India Infoline2 months ago Biocon collaborates with Advaxis for 'ADXS-HPV'  India Infoline2 months ago Biocon Q3 net profit at Rs6596.50 mn  India Infoline2 months ago
[x]  
Livemint.com

NOVARTIS : Files patent suit against biocon over diabetes drug galvus

04/08/2014 | 07:28am US/Eastern Recommend: Pharmaceutical major Novartis of Switzerland has filed patent infringement proceedings at the Delhi High Court (HC) against Biocon Limited of Bangalore to stop it from launching a ...
 4 Traders1 week ago NOVARTIS : Sues biocon for patent breach  4 Traders1 week ago Drugmaker Novartis files patent suit against Biocon over Galvus  Yahoo! India6 days ago NOVARTIS FILES PATENT INFRINGEMENT SUIT AGAINST BIOCON  4 Traders1 week ago
[x]  

5 reasons why BJP's manifesto stands apart

, Chairman and Managing Director of Biocon has written a blog on five reasons why BJP's manifesto stands apart from that of other political parties. Below is an exact reproduction of what she has written: The BJP seems to have invested a lot of ...
 Economic Times1 week ago

Biocon's FY14 results on April 24, 2014

Biocon has informed that a meeting of the Board of Directors of the Company will be held on April 24, 2014, to approve and take on record the audited financial results for the year ended on March 31, 2014 and consider recommendation for payment of dividend, ...
 Money Control1 week ago Biocon to hold board meeting  Business Standard1 week ago Biocon - FY14 results on April 24, 2014  SBICAP Securities1 week ago
The Local Switzerland

Biocon rejects Novartis patent infringement charge

Leading Indian drug company Biocon yesterday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus. Novartis announced on Thursday it was seeking an injunction in ...
 Pharmaceutical & Medical Packaging News1 week ago India drugs giant rejects Novartis patent accusations  MENAFN1 week ago Indian drug rival denies Novartis patent charges  The Local Switzerland1 week ago Biocon rejects Novartis patent accusations  Qatar Peninsula1 week ago
[x]  

Biocon counters Novartis charge over diabetes drug in HC

New Delhi, Apr 4 (PTI) Leading Indian drug company Biocon today countered in the Delhi High Court the allegation of Novartis that it had infringed upon the patent right of the Swiss pharmaceutical giant over its diabetes drug Galvus. The Indian ...
 Press Trust of India1 week ago
Sify

Biocon - Shareholding Pattern for March 31, 2014

Biocon Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March
 Religare Securities1 week ago Positive start, L&T, Biocon eyed  India Infoline1 month ago F&O QUERY CORNER: BIOCON  Business Line2 months ago Biocon shares slump on earnings disappointment  Sify2 months ago
[x]  

Biocon clarifies on bonus news

Biocon Ltd has clarified with reference to the news item appearing in the media titled "Bonus Buzz in Biocon". The company has denied the news item. Shares of BIOCON LTD. was last trading in BSE at Rs.451.55 as compared to the previous close of ...
 Equity Bulls10 hours ago Biocon - Clarifies on News item  SBICAP Securities22 hours ago Biocon clarifies on news item  Money Control7 hours ago
Money Today

Novartis patent suit: Biocon denies any court injunction

(Photo: Reuters) "Biocon will not manufacture, sell or export Vildagliptin (a diabetes drug) for commercial purposes till the next court hearing," says a statement from Swiss drug major Novartis. The Basel-based firm has filed infringement proceedings and is ...
 Money Today1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less